A new study has found that the second dose of the Pfizer vaccine produces a 3.5-times greater antibody response when given at 12 weeks, compared to three weeks.
Lorraine Smith, Divisional Managing Director at Civica, discusses how the pandemic has not only re-shaped local government when it comes to new ways of working but also in transforming citizen engagement.
Adam Enterkin, Global SVP Sales at BlackBerry, explores the critical role of secure crisis communications for the vaccine rollout and the value of a communication strategy to combat misinformation.
Researchers from Northwestern Medicine have studied the placentas from patients who received the COVID-19 vaccine during pregnancy and found no evidence of damage.
Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.
Peter Seldon, CEO, Consultus Care & Nursing, explores the impact of COVID-19 and mental health within social care settings and what best practices can be adopted to support both carers and clients.
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that all under 40s should be offered an alternative to the Oxford/AstraZeneca vaccine following blood clot risk.
